Abstract:Pan-assay interference compounds (PAINS) are promiscuous compound classes that produce false positive hits in high-throughput screenings. Yet, the mechanisms of PAINS activity are poorly understood. Although PAINS are often associated with protein reactivity, several recent studies have shown that they also mediate noncovalent interactions. Aiming at a deep understanding of PAINS promiscuity, we performed an analysis of the Protein Data Bank to characterize the binding modes of PAINS. We explored the binding mode conservation of 34 PAINS classes present in 871 ligands and among 517 protein targets. The two major findings of this work are the following: First, different PAINS classes exhibit different levels of binding mode conservation. Our novel classification of PAINS based on binding mode similarity enables a rational assessment of PAINS from a structural perspective. Second, PAINS classes with variable binding modes can bind with high affinity. The evaluation of noncovalent binding modes of PAINS-like compounds sheds light on the mechanisms of promiscuous binding. Our findings could facilitate the decisions on how to deal with PAINS and help scientists to understand why PAINS produce hits in their screenings.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01227?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01227</a>.Lipinski's rule of five tested for PAINS, interaction level determination, histograms of PAINS data, influence of PAINS size, and chemical similarity on binding mode similarity (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_001.pdf">PDF</a>)Description and explanation of the Supporting Information files (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_002.zip">ZIP</a>)Pairwise combinations of PAINS compounds with PAINS class, ligand–target interaction level, Tanimoto interaction similarity, and protein sequence identity (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_003.zip">ZIP</a>)Evaluation of Lipinski's rule in PAINS compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_004.zip">ZIP</a>)Evaluation of Lipinski's rule in PAINS-defining substructures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_005.zip">ZIP</a>)Frequency of non-PAINS substructures among non-PAINS (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_006.zip">ZIP</a>)Interaction and atom proportion of PAINS classes (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_007.zip">ZIP</a>)Ligand InChI keys, SMILES, PAINS classes, and PDB IDs for all ligands that were part of the binding mode similarity analysis (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_008.zip">ZIP</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01227/suppl_file/ci0c01227_si_009.zip">ZIP</a>)This article has not yet been cited by other publications.

Optimization of an in Silico Protocol Using Probe Permeabilities to Identify Membrane Pan-Assay Interference Compounds

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

pMD-Membrane: A Method for Ligand Binding Site Identification in Membrane-Bound Proteins

PrePeP: A Tool for the Identification and Characterization of Pan Assay Interference Compounds

Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes

Molecular Transport Through Membranes: Accurate Permeability Coefficients from Multidimensional Potentials of Mean Force and Local Diffusion Constants

Optimization of a Parallel Artificial Membrane Permeability Assay for the Fast and Simultaneous Prediction of Human Intestinal Absorption and Plasma Protein Binding of Drug Candidates: Application to Dibenz[b,f]azepine-5-Carboxamide Derivatives

Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development

Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands

Comparison of in vitro membrane permeabilities of diverse environmental chemicals with in silico predictions

Advances in Parallel Artificial Membrane Permeability Assay and Its Applications

Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations

A Novel Design of Artificial Membrane for Improving the PAMPA Model

Assessing the Intestinal Permeability of Small Molecule Drugs Via Diffusion Motion on a Multidimensional Free Energy Surface.

Highly predictive and interpretable models for PAMPA permeability

Exploring Activity Profiles of PAINS and Their Structural Context in Target-Ligand Complexes

A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.

Improving the Accuracy of Permeability Data to Gain Predictive Power: Assessing Sources of Variability in Assays Using Cell Monolayers

Towards Intelligent Drug Design System: Application of Artificial Dipeptide Receptor Library in QSAR-Oriented Studies

Liposomes as biomembrane models: Biophysical techniques for drug-membrane interaction studies

Interaction of Near-Infrared (NIR)-Light Responsive Probes with Lipid Membranes: A Combined Simulation and Experimental Study